HOXA11 hypermethylation is associated with progression of non-small cell lung cancer

Oncotarget

Volumn 4, Issue 12, 2013, Pages 2317-2325

  Hwang, Jung Ah ^a   Lee, Bo Bin ^b   Kim, Yujin ^b   Park, Seong Eun ^b   Heo, Kyun ^a   Hong, Seung Hyun ^a   Kim, Young Ho ^b   Han, Joungho ^b   Shim, Young Mog ^b   Lee, Yeon Su ^a   Kim, Duk Hwan ^b  

^a National Cancer Center   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

HOXA11; Hypermethylation; Migration; Non small cell lung cancer; Progression

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; KI 67 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BRONCHUS MUCOSA; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER PATIENT; CANCER STAGING; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN H23; CONTROLLED STUDY; DNA METHYLATION; EPITHELIUM CELL; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HOXA11 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; PRIMARY TUMOR; PROMOTER REGION; TISSUE PRESERVATION;

AZACITIDINE; CARCINOMA, NON-SMALL-CELL LUNG; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; DNA METHYLATION; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PARAFFIN EMBEDDING; PROMOTER REGIONS, GENETIC; TRANSFECTION;

EID: 84891956154     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1464     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2005; 58: 71-96.
2. Kim JS, Kim JW, Han J, Shim YM, Park J, Kim DH. Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer. Cancer Res. 2006; 66: 4049-4054.
3. Golpon HA, Geraci MW, Moore MD, Miller HL, Miller GJ, Tuder RM, Voelkel NF. HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema. Am J Pathol. 2001; 158: 955-966.
4. Krumlauf R. Hox genes in vertebrate development. Cell. 1994; 78: 191-201.
5. Rauch T, Wang Z, Zhang X, Zhong X, Wu X, Lau SK, Kernstine KH, Riggs AD, Pfeifer GP. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc Natl Acad Sci U S A. 2007; 104: 5527-5532.
6. Bibikova M, Lin Z, Zhou L, Chudin E, Garcia EW, Wu B, Doucet D, Thomas NJ, Wang Y, Vollmer E, Goldmann T, Seifart C, Jiang W, Barker DL, Chee MS, Floros J, et al. High-throughput DNA methylation profiling using universal bead arrays. Genome Res. 2006; 16: 383-393.
7. Olaussen KA, Soria JC, Park YW, Kim HJ, Kim SH, Ro JY, André F, Jang SJ. Assessing abnormal gene promoter methylation in paraffin-embedded sputum from patients with NSCLC. Eur J Cancer. 2002; 41: 2112-2119.
8. Nelson HH, Marsit CJ, Christensen BC, Houseman EA, Kontic M, Wiemels JL, Karagas MR, Wrensch MR, Zheng S, Wiencke JK, Kelsey KT. Key epigenetic changes associated with lung cancer development: Results from dense methylation array profiling. Epigenetics. 2012; 7: 559-566.
9. Fiegl H, Windbichler G, Mueller-Holzner E, Goebel G, Lechner M, Jacobs IJ, Widschwendter M. HOXA11 DNA methylation--a novel prognostic biomarker in ovarian cancer. Int J Cancer. 2008; 123: 725-729.
10. Widschwendter M, Apostolidou S, Jones AA, Fourkala EO, Arora R, Pearce CL, Frasco MA, Ayhan A, Zikan M, Cibula D, Iyibozkurt CA, Yavuz E, Hauser-Kronberger C, Dubeau L, Menon U, Jacobs IJ. HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: a proof of principle study. Int J Cancer. 2009; 125: 2214-2218.
11. Martinez R, Martin-Subero JI, Rohde V, Kirsch M, Alaminos M, Fernandez AF, Ropero S, Schackert G, Esteller M. A microarray-based DNA methylation study of glioblastoma multiforme. Epigenetics. 2009; 4: 255-264.
12. Bennett LB, Schnabel JL, Kelchen JM, Taylor KH, Guo J, Arthur GL, Papageorgio CN, Shi H, Caldwell CW. DNA hypermethylation accompanied by transcriptional repression in follicular lymphoma. Genes Chromosomes Cancer. 2009; 48: 828-841.
13. Whitcomb BP, Mutch DG, Herzog TJ, Rader JS, Gibb RK, Goodfellow PJ. Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma. Clin Cancer Res. 2003; 9: 2277-2287.
14. Apostolidou S, Hadwin R, Burnell M, Jones A, Baff D, Pyndiah N, Mould T, Jacobs IJ, Beddows S, Kocjan G, Widschwendter M. DNA methylation analysis in liquid-based cytology for cervical cancer screening. Int J Cancer. 2009; 125: 2995-3002.
15. Fatemi M, Hermann A, Gowher H, Jeltsch A. Dnmt3a and Dnmt1 functionally cooperate during de novo methylation of DNA. Eur J Biochem. 2001; 269: 4981-4984.
16. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE, Cui H, Feinberg AP, Lengauer C, Kinzler KW, Baylin SB, Vogelstein B. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature. 2001; 416: 552-556.
17. Belinsky SA, Nikula KJ, Baylin SB, Issa JP. Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc Natl Acad Sci U S A. 1996; 93: 4045-4050.
18. Swafford DS, Middleton SK, Palmisano WA, Nikula KJ, Tesfaigzi J, Baylin SB, Herman JG, Belinsky SA. Frequent aberrant methylation of p16INK4A in primary rat lung tumors. Mol Cell Biol. 1997; 17: 1366-1374.
19. Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC, Wain JC, Mark EJ, Kelsey KT. p16INK4a and histologyspecific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res. 2001; 61: 3419-3424.
20. Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA, Crowell RE. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res. 2001; 62: 2370-2377.
21. Edge SB, Byrd DR, Compton CC, Fritz AF, Greene FL, Trotti A. American Joint Committee on Cancer. In: AJCC Cancer Staging Manual. (7th edn), New York: Springer; 2010. p 253-270.
22. Kim JS, Han J, Shim YM, Park J, Kim DH. Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma. Cancer. 2005; 104: 1825-1833.